Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pomalidomide, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma
NCT02176213Phase 2Completed
- Start
- Jun 2014
- Primary completion
- May 2019
- Modality
- Molecular Glues
- Countries
- 1
01
Overview
A Phase 2 trial of pomalidomide in multiple myeloma (MM). Started Jun 2014; status: completed.
02
Drugs
pomalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02176213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02176213.